Eli Lilly on Thursday launched in India its diabetes and weight-loss drug, Mounjaro, which has already clocked in over $20 ...
A treat-to-target study of upadacitinib in atopic dermatitis showed that dosing can be adjusted depending on early patient ...
Eli Lilly (LLY) has launched its weight-loss and diabetes drug, Mounjaro (tirzepatide), in India, securing a first-mover ...
Sun Pharmaceutical Industries Ltd. closed 12.97% below its 52-week high of 1,960.20 rupees, which the company achieved on ...
With Sun Pharmaceutical Industries currently trading at Rs 1786.50, the stock has demonstrated strong momentum, supported by ...
Sun Pharma and Zydus Pharmaceuticals are recalling significant quantities of their products in the US due to manufacturing ...
Sun Pharmaceutical Industries Limited has announced the completion of its 100% acquisition of Antibe Therapeutics Inc., a ...
The companies in question, Dr. Reddy’s Laboratories, Sun Pharma and Zydus Pharmaceuticals, are recalling seizure treatments, ...
Sun Pharmaceuticals Industries Ltd is quoting at Rs 1699.6, up 0.96% on the day as on 12:44 IST on the NSE. The stock is up 8.17% in last one year as compared to a 1.86% gain in NIFTY and a 9.69% gain ...
The Print on MSN2d
How reciprocal Trump tariffs may impact Indian pharma, and become a bitter pill for the USSpooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...
Sun Pharmaceutical Industries, Inc., based in New Jersey, has recalled 9,840 bottles of Morphine Sulfate extended-release ...
Sun Pharmaceutical Industries Ltd. closed 10.79% short of its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback